Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Clinical Sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital

Detection Principle
NucleicAcid-PCR based
N; ORF1a, E; N, E (PCR); IgG, IgA, IgM vs RBD (ELISA)
Testing Method Category
Testing Method
Kits & in house
Testing Method - Additional Info
LDT , cobas® SARS-CoV-2 (Roche), Xpert Xpress; ELISA
Reported Performance
PCR Sensitivity: 90% (<5 dpo), 70-71% (9-11 dpo), 30% (>21 dpo); serological sensitivity: >50% (>7 dpo), >80% (>12 dpo), 100% (>21 dpo)
Sample Size
209 patients (with several tests each)

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements